
In:
The Lancet
andere Autoren:
Tammam Aloudat
Erscheinungsdatum:
2017
Edition:
Vol. 389 , Iss. 10073 , pp. 1007-1008
We challenge the assertion made by Govind Persad and Ezekiel Emanuel (Aug 27, p 932) that “expanding access to less effective or more toxic [antiretroviral] treatments rather than requiring the worldwide best treatment in all settings” is ethically justifiable.